Sonodynamic therapy (SDT): A novel treatment of cancer based on sonosensitizer liposome as a new drug carrier

Medical Hypotheses

Volumn 80, Issue 3, 2013, Pages 300-302

  Dai, Zhi Jun ^a   Li, Sha ^a   Gao, Jie ^a   Xu, Xiao Na ^a   Lu, Wang Feng ^a   Lin, Shuai ^a   Wang, Xi Jing ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; LIPOSOME;

ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CHEMOSENSITIZATION; FLUORESCENCE IMAGING; NONHUMAN; SONODYNAMIC THERAPY; ULTRASOUND THERAPY;

ANTINEOPLASTIC AGENTS; DRUG CARRIERS; HUMANS; LIPOSOMES; MODELS, THEORETICAL; NEOPLASMS; ULTRASONIC THERAPY;

EID: 84874509007     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.12.009     Document Type: Article

References (38)

1. Timothy J.M. The proliferation rate paradox in antimitotic chemotherapy. Mol Biol Cell 2012, 23:1-6.
2. Umemura S., Yumita N., Nishigaki R., Umemura K. Mechanism of cell damage by ultrasound in combination with hematoporphyrin. Jpn J Cancer Res 1990, 81:962-966.
3. Yumita N., Okuyama N., Sasaki K., Umemura S. Sonodynamic therapy on chemically induced mammary tumor: pharmacokinetics, tissue distribution and sonodynamically induced antitumor effect of gallium-porphyrin complex ATX-70. Cancer Chemoth Pharm 2007, 60:891-897.
4. He Y., Xing D., Yan G., Ueda K. FCLA chemiluminescence from sonodynamic action in vitro and in vivo. Cancer Lett 2002, 182:141-145.
5. Tsuru H., Shibaguchi H., Kuroki M., Yamashita Y., Kuroki M. Tumor growth inhibition by sonodynamic therapy using a novel sonosensitizer. Free Radic Biol Med 2012, 53:464-472.
6. Nielsen K.P., Juzeniene A., Juzenas P., Stamnes K., Stamnes J.J., Moan J. Choice of optimal wavelength for PDT: the significance of oxygen depletion. Photochem Photobiol 2005, 81:1190-1194.
7. Jin Z., Lan G.Q., Post M., Simard B., Deslandes Y., Hsieh T.H. Design of nanoparticles as drug carriers for cancer therapy. Cancer Genomics Proteomics 2006, 3:147-158.
8. Li D.C., Zhong X.K., Zeng Z.P., Jiang J.G., Li L., Zhao M.M., et al. Application of targeted drug delivery system in Chinese medicine. J Control Release 2009, 138:103-112.
9. Huwyler J., Drewe J., Krahenbuhl S. Tumor targeting using liposomal antineoplastic drugs. Int J Nanomedicine 2008, 3:21-29.
10. Kwon I.K., Lee S.C., Han B., Park K. Analysis on the current status of targeted drug delivery to tumors. J Control Release 2012, 164:108-114.
11. Liang H.D., Tang J., Halliwell M. Sonoporation, drug delivery, and gene therapy. Proc Inst Mech Eng H 2010, 224:343-361.
12. Rosenthal I., Sostaric J.Z., Riesz P. Sonodynamic therapy-a review of the synergistic effects of drugs and ultrasound. Ultrason Sonochem 2004, 11:349-363.
13. Terdaeme O.N., Leslie T.A., Kennedy J.E., Philips R.R., Brady M. The use of time to maximum enhancement to indicate areas of ablation following the treatment of liver tumours with highintensity focused ultrasound. Brit J Radiol 2009, 82:412-420.
14. Sassaroli E., Hynynen K. Cavitation threshold of microbubbles in gel tunnels by focused ultrasound. Ultrasound Med Biol 2007, 33:1651-1660.
15. Wiedemair W., Tukovic Z., Jasak H., Poulikakos D., Kurtcuoglu V. On ultrasound-induced microbubble oscillation in capillary blood vessel and its implications for the blood-brain barrier. Phys Med Biol 2012, 57:1019-1045.
16. Zderic V., Clark J.I., Martin R.W., Vaezy S. Ultrasound-enhanced transcorneal drug delivery. Cornea 2004, 23:804-811.
17. Husseini G.A., Pitt W.G. The use of ultrasound and micelles in cancer treatment. J Nanosci Nanotechnol 2008, 8:2205-2215.
18. Miller D.L., Dou C.Y. Induction of apoptosis in sonoporation and ultrasonic gene transfer. Ultrasound Med Biol 2009, 35:144-154.
19. Tang W., Liu Q., Wang X., Mi N., Wang P., Zhang J. Membrane fluidity altering and enzyme inactivating in sarcoma 180 cells post the exposure to sonoactivated hematoporphyrin in vitro. Ultrasonics 2008, 48:66-73.
20. Yumita Nagahiko, Lwase Y., Nishi K., Komatsu H., Takeda K., Onodera K., et al. Involvement of reactive oxygen species in sonodynamically induced apoptosis using a novel porphyrin derivative. Theranostics 2012, 2:880-888.
21. Yu T., Huang X., Hu K., Bai J., Wang Z. Mechanisms of reversal of adriamycin resistance in hum an ovarian carcinom a cell line by ultrasound. Int J Gynecol Cancer 2004, 14:76-81.
22. Lv Y.H., Fang M., Zheng J.H., Yang B., Li H.X., Zhong X.G. Low-intensity ultrasound combined with 5-aminolevulinic acid administration in the treatment of human tongue squamous carcinoma. Cell Physiol Biochem 2012, 30:321-333.
23. Orel D., Rozman J. A computer silulation of ultrasound thermal bio-effect in embryonic models. Radioengineering 2003, 12:26-30.
24. Barnett S.B. Intracranial temperature elevation from diagnostic ultrasound. Ultrasound Med Biol 2001, 27:883-888.
25. Shaul O., Doron S. Ultrasonic transcutaneous energy transfer for powering implanted devices. Ultrasonics 2010, 50:556-566.
26. Victor F. Ultrasound mediated delivery of drugs and genes to solid tumors. Adv Drug Deliv Rev 2008, 60:1193-1208.
27. Zhao J.H., Yu L.L., Hui C., Huang B.F., Li C., Zhao Q., et al. Study on sound field of high intensity focused ultrasound with short focal length. AMM 2012, 195-196:364-369.
28. 3 nanoparticles in VX2 carcinoma-induced liver tumors. PLoS One 2011, 6:1-12.
29. Besic E. Physical mechanisms and methods employed in drug delivery to tumors. Acta Pharm 2007, 57:249-268.
30. Newman C.M., Bettinger T. Gene therapy progress and prospects: ultrasound for gene transfer. Gene Ther 2007, 14:465-475.
31. Nidich S.I., Fields J.Z., Rainforth M.V., Pomertantz R., Cella D., Kristeller J., et al. A randomized controlled trial of the effects of transcendental meditation on quality of life in older breast cancer patients. Integr Cancer Ther 2009, 8:228-234.
32. Yu T., Bai J., Hu K., Wang Z. Biological effects of ultrasound exposure on adriamycin-resistant and cisplatin-resistant humanovarian carcinoma cell lines in vitro. Ultrason Sonochem 2004, 11:89-94.
33. Menno L., Wim J.B., Stefan R.V., Robert J.V., Martin A.V., Debby S., et al. Enriching lipid nanovesicles with short-chain glucosylceramide improves doxorubicin delivery and efficacy in solid tumors. FASEB J 2011, 25:280-289.
34. Lowery A., Onishko H., Hallahan D.E., Han Z. Tumor-targeted delivery of liposome-encapsulated doxorubicin by use of a peptide that selectively binds to irradiated tumors. J Control Release 2011, 150:117-124.
35. Kaminskas L.M., McLeod V.M., Kelly B.D., Sberna G., Boyd B.J., Williamson M., et al. A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systems. Nanomed-nanothechnol 2012, 8:103-111.
36. Marin A., Muniruzzaman M., Rapoport N. Mechanism of the ultrasonic activation of micellar drug delivery. J Control Release 2001, 75:69-81.
37. Rapoport N. Combined cancer therapy by micellar-encapsulated drug andultrasound. Int J Pharm 2004, 277:155-162.
38. Jackson J.K., Pirmoradi F.N., Wan C.P., Siu T., Chiao M., Burt H.M. Increased accumulation of paclitaxel and doxorubicin in proliferating capillary cells and prostate cancer cells following ultrasound exposure. Ultrasonics 2011, 51:932-939.